WO2007026049A2 - Improved method for fermentation by repairing yeast genes - Google Patents
Improved method for fermentation by repairing yeast genes Download PDFInfo
- Publication number
- WO2007026049A2 WO2007026049A2 PCT/FI2006/000292 FI2006000292W WO2007026049A2 WO 2007026049 A2 WO2007026049 A2 WO 2007026049A2 FI 2006000292 W FI2006000292 W FI 2006000292W WO 2007026049 A2 WO2007026049 A2 WO 2007026049A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gene
- yeast
- maltose
- strain
- sequence
- Prior art date
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 185
- 238000000855 fermentation Methods 0.000 title claims abstract description 63
- 230000004151 fermentation Effects 0.000 title claims abstract description 63
- 238000000034 method Methods 0.000 title claims abstract description 63
- 108090000623 proteins and genes Proteins 0.000 title claims description 270
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims abstract description 154
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims abstract description 154
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 claims abstract description 98
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 claims abstract description 98
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 claims abstract description 98
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 claims abstract description 98
- 108020004414 DNA Proteins 0.000 claims abstract description 75
- 230000010354 integration Effects 0.000 claims abstract description 59
- 239000002773 nucleotide Substances 0.000 claims abstract description 51
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 51
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims abstract description 50
- 230000009466 transformation Effects 0.000 claims abstract description 39
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 15
- 102000053602 DNA Human genes 0.000 claims abstract description 11
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 175
- 108010078791 Carrier Proteins Proteins 0.000 claims description 143
- 150000008494 α-glucosides Chemical class 0.000 claims description 65
- 210000000349 chromosome Anatomy 0.000 claims description 61
- 230000007547 defect Effects 0.000 claims description 59
- 230000002950 deficient Effects 0.000 claims description 48
- 230000000694 effects Effects 0.000 claims description 38
- 150000001413 amino acids Chemical class 0.000 claims description 27
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 22
- 239000008103 glucose Substances 0.000 claims description 22
- 239000000758 substrate Substances 0.000 claims description 19
- 108020004485 Nonsense Codon Proteins 0.000 claims description 15
- 241000235070 Saccharomyces Species 0.000 claims description 14
- 230000037433 frameshift Effects 0.000 claims description 13
- 108091026890 Coding region Proteins 0.000 claims description 12
- 108020004705 Codon Proteins 0.000 claims description 12
- 108091081024 Start codon Proteins 0.000 claims description 7
- 230000006698 induction Effects 0.000 claims description 7
- 238000012216 screening Methods 0.000 claims description 7
- 230000006801 homologous recombination Effects 0.000 claims description 4
- 238000002744 homologous recombination Methods 0.000 claims description 4
- 230000008030 elimination Effects 0.000 claims description 2
- 238000003379 elimination reaction Methods 0.000 claims description 2
- 239000013612 plasmid Substances 0.000 description 42
- 210000004027 cell Anatomy 0.000 description 39
- 239000000523 sample Substances 0.000 description 35
- 235000001014 amino acid Nutrition 0.000 description 25
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 24
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 24
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 24
- 230000008439 repair process Effects 0.000 description 22
- 235000013405 beer Nutrition 0.000 description 21
- 102000004169 proteins and genes Human genes 0.000 description 21
- 235000000346 sugar Nutrition 0.000 description 21
- 235000018102 proteins Nutrition 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 101100075883 Saccharomyces cerevisiae MAL61 gene Proteins 0.000 description 18
- 239000003550 marker Substances 0.000 description 18
- 230000012010 growth Effects 0.000 description 17
- 238000009396 hybridization Methods 0.000 description 17
- 239000012634 fragment Substances 0.000 description 16
- 101100075884 Saccharomyces cerevisiae MAL62 gene Proteins 0.000 description 15
- 230000005484 gravity Effects 0.000 description 15
- 150000008163 sugars Chemical class 0.000 description 15
- UIFFUZWRFRDZJC-UHFFFAOYSA-N Antimycin A1 Natural products CC1OC(=O)C(CCCCCC)C(OC(=O)CC(C)C)C(C)OC(=O)C1NC(=O)C1=CC=CC(NC=O)=C1O UIFFUZWRFRDZJC-UHFFFAOYSA-N 0.000 description 14
- NQWZLRAORXLWDN-UHFFFAOYSA-N Antimycin-A Natural products CCCCCCC(=O)OC1C(C)OC(=O)C(NC(=O)c2ccc(NC=O)cc2O)C(C)OC(=O)C1CCCC NQWZLRAORXLWDN-UHFFFAOYSA-N 0.000 description 14
- UIFFUZWRFRDZJC-SBOOETFBSA-N antimycin A Chemical compound C[C@H]1OC(=O)[C@H](CCCCCC)[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)[C@H]1NC(=O)C1=CC=CC(NC=O)=C1O UIFFUZWRFRDZJC-SBOOETFBSA-N 0.000 description 14
- PVEVXUMVNWSNIG-UHFFFAOYSA-N antimycin A3 Natural products CC1OC(=O)C(CCCC)C(OC(=O)CC(C)C)C(C)OC(=O)C1NC(=O)C1=CC=CC(NC=O)=C1O PVEVXUMVNWSNIG-UHFFFAOYSA-N 0.000 description 14
- 238000012163 sequencing technique Methods 0.000 description 14
- 101100075885 Saccharomyces cerevisiae MAL63 gene Proteins 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 108700028369 Alleles Proteins 0.000 description 12
- FDQGNLOWMMVRQL-UHFFFAOYSA-N Allobarbital Chemical compound C=CCC1(CC=C)C(=O)NC(=O)NC1=O FDQGNLOWMMVRQL-UHFFFAOYSA-N 0.000 description 11
- 230000005764 inhibitory process Effects 0.000 description 11
- 238000003906 pulsed field gel electrophoresis Methods 0.000 description 11
- 239000013598 vector Substances 0.000 description 11
- 108091028043 Nucleic acid sequence Proteins 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 239000000499 gel Substances 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 210000005253 yeast cell Anatomy 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000010367 cloning Methods 0.000 description 8
- HOVAGTYPODGVJG-ZFYZTMLRSA-N methyl alpha-D-glucopyranoside Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HOVAGTYPODGVJG-ZFYZTMLRSA-N 0.000 description 8
- 238000013459 approach Methods 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 101150088659 mal3 gene Proteins 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 101000962438 Homo sapiens Protein MAL2 Proteins 0.000 description 6
- 108700026244 Open Reading Frames Proteins 0.000 description 6
- 102100039191 Protein MAL2 Human genes 0.000 description 6
- 101100290055 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MAL13 gene Proteins 0.000 description 6
- 241001123227 Saccharomyces pastorianus Species 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000002068 genetic effect Effects 0.000 description 6
- 101100075880 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MAL33 gene Proteins 0.000 description 5
- 230000003322 aneuploid effect Effects 0.000 description 5
- 208000036878 aneuploidy Diseases 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 108010056929 lyticase Proteins 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- BRZYSWJRSDMWLG-DJWUNRQOSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-[(1r)-1-hydroxyethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-DJWUNRQOSA-N 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 108091008109 Pseudogenes Proteins 0.000 description 4
- 102000057361 Pseudogenes Human genes 0.000 description 4
- 101000767160 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Intracellular protein transport protein USO1 Proteins 0.000 description 4
- 101100290064 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MAL31 gene Proteins 0.000 description 4
- 108010028144 alpha-Glucosidases Proteins 0.000 description 4
- 235000013930 proline Nutrition 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 3
- 229910009891 LiAc Inorganic materials 0.000 description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- 108091006243 SLC7A13 Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 102100023135 Solute carrier family 7 member 13 Human genes 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 101150050575 URA3 gene Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000012190 activator Substances 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 102000016679 alpha-Glucosidases Human genes 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000002018 overexpression Effects 0.000 description 3
- 230000008560 physiological behavior Effects 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 230000000644 propagated effect Effects 0.000 description 3
- 230000006798 recombination Effects 0.000 description 3
- 238000005215 recombination Methods 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001131 transforming effect Effects 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 108091033380 Coding strand Proteins 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 2
- 101100446506 Mus musculus Fgf3 gene Proteins 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- -1 acids acids Chemical class 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 238000005189 flocculation Methods 0.000 description 2
- 230000016615 flocculation Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 description 1
- 101100394866 Arabidopsis thaliana HIPP47 gene Proteins 0.000 description 1
- 108010023063 Bacto-peptone Proteins 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010058643 Fungal Proteins Proteins 0.000 description 1
- 101100246753 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) pyrF gene Proteins 0.000 description 1
- 108050002021 Integrator complex subunit 2 Proteins 0.000 description 1
- 102100033265 Integrator complex subunit 2 Human genes 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 101150030468 MPH3 gene Proteins 0.000 description 1
- 108090000301 Membrane transport proteins Proteins 0.000 description 1
- 102000003939 Membrane transport proteins Human genes 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 241000235072 Saccharomyces bayanus Species 0.000 description 1
- 101100290054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MAL12 gene Proteins 0.000 description 1
- 108091081400 Subtelomere Proteins 0.000 description 1
- 239000008051 TBE buffer Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 101150111557 ale gene Proteins 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 239000011538 cleaning material Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 235000003869 genetically modified organism Nutrition 0.000 description 1
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003148 prolines Chemical class 0.000 description 1
- 238000001853 pulsed-field electrophoresis Methods 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000007222 ypd medium Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C11/00—Fermentation processes for beer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C12/00—Processes specially adapted for making special kinds of beer
- C12C12/002—Processes specially adapted for making special kinds of beer using special microorganisms
- C12C12/004—Genetically modified microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C11/00—Fermentation processes for beer
- C12C11/003—Fermentation of beerwort
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C12/00—Processes specially adapted for making special kinds of beer
- C12C12/002—Processes specially adapted for making special kinds of beer using special microorganisms
- C12C12/006—Yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/905—Stable introduction of foreign DNA into chromosome using homologous recombination in yeast
Definitions
- This invention relates to methods for changing the physiological behaviour of yeasts, in particular brewer's yeasts, by altering the arrangement of their genetic material.
- it relates to methods to increase the fermentation capacity of brewer's yeast by increasing the activity of their maltose and maltotriose transporters.
- Brewer's yeast ferment the sugars in brewer's wort to produce mainly ethanol. At the same time they also produce various chemical side products that contribute to the flavour of the beer.
- the main sugars in wort are maltose (about 60 % of the total), maltotriose (about 20 %) and glucose (about 20 %).
- the sugars are fermented in the order glucose, maltose, maltotriose. It is believed that the rate at which maltose and maltotriose can enter the yeast cell (the uptake rate or transport rate) limits the speed of wort fermentations (see, e.g., Kodama et al [1995] J.Am. Soc. Brew. Chem.
- Breweries now-a-days use increasingly strong (higher gravity) worts that contain up to 200 g of sugar/L, more than twice the traditional levels. Use of these very high gravity worts can improve the economics of beer production and also decrease the environmental costs (e.g., there are savings in energy consumption and the use of cleaning materials). To achieve these benefits it is important that the speed of fermentation is adequate and, especially, that the amount of residual sugars does not increase by more than the increase in wort gravity.
- residual sugars are a major problem with very high gravity fermentation, and unacceptably large amounts of maltose and, especially, maltotriose are frequently left unfermented.
- brewer's yeast collected from one fermentation was used to start the next fermentation. This process has been continued for hundreds of years.
- strains of brewer's yeasts have been automatically selected to survive and reproduce well under brewery conditions.
- strains of brewer's yeast contain multiple genes for ⁇ -glucoside transporters.
- Maltose and maltotriose are both ⁇ -glucosides.
- Some ⁇ -glucoside transporters have broad substrate specificity and can carry several ⁇ -glucosides including maltose and maltotriose.
- brewer's yeasts have evolved for hundreds of years in brewer's wort, high and very high gravity worts have been introduced only during the last decades. By the time of their introduction, most breweries no longer re-cycled their yeast continuously. Instead pure cultures of the brewer's own strains are stored in a collection and at regular intervals fresh lots of yeast are grown up from these cultures and taken into use. This means that the natural evolutionary adaptation to brewery conditions has stopped. This in turn suggests that present day strains could be significantly improved: they have not reached an evolutionary limit.
- One way to improve brewer's yeast strains is to isolate spontaneous or mutagen-induced variants with improved performance. Another way is to combine the genetic potential of different yeast strains to create a new improved strain.
- hybridisation is a long and inefficient process that cannot be applied to all brewer's strains, and the genetic outcome is uncertain. Usually many other characters will be altered as well as the desired character. In the brewery context altered factors are likely to include flavour production and process behaviour.
- Another approach is to use genetic engineering techniques to rearrange the DNA of a particular yeast strain or to move DNA from one yeast strain to another. This can be done in such a way that the new yeast strain does not contain DNA from any non-
- Ale strains are Sacharomyces cerevisiae, but they are genetically more complicated than laboratory strains of S. cerevisiae: in particular they are usually aneuploid, i.e., each cell contains more than one copy of each chromosome but not necessarily the same number of copies of all chromosomes.
- Ale strains are probably closely related to baker's yeasts.
- Lager strains on the other hand are thought to be the result of one or more hybridisation events between a S. cerevisiae strain and some other, closely related, yeast species, possibly S. bayanus.
- Ale, lager, and baker's yeasts and laboratory strains of S. cerevisiae share much of their genetic information and provide a large pool of genetic variation that can be usefully exploited.
- brewer's yeast strains to transport maltose and maltotriose across their cell membranes into the cytosol (Kodama et al [1995] J. Am. Soc. Brew Chem. 53, 24-29, Rautio & Londesborough [2003] J. Inst. Brew..109, 251-261).
- capacity to transport maltose we mean the speed at which yeast cells can take up maltose from the medium across the cell membrane and into the cell, measured, e.g., as ⁇ mol of maltose/minute/g of dry yeast.
- the transformed strain contains non-yeast (bacterial) DNA, which is a disadvantage for applications in the food and drink industry because of public attitudes and official regulations. Furthermore, the high-copy-number plasmids are not genetically stable and selection pressure is required to maintain these plasmids in the yeast. Kodama et al, carried out their fermentations in wort containing the antibiotic G418 to provide selection pressure.
- Patent publication EP 0306107 Bl describes baker's yeast strains in which the complete coding sequence of a maltose transporter gene has been provided with a new promoter and terminator (e.g. from the yeast ADHl gene) and this construct is then integrated into a yeast gene. This strategy results in the loss of one gene from the yeast.
- EP 0306107 Bl recognised this problem, and therefore chose to integrate the DNA construct into the SITl gene (EP 0306107 Bl, loc .cit see pl4, lines 17 et seq.), in the belief that the SITl gene is not needed by the baker's yeast during the industrial process. Nevertheless, the transformed yeast lacks at least one copy of the SITl gene. This could have unforeseen consequences, especially in the beer production process, where the exact physiological behaviour of the yeast impacts on flavour formation and yeast handling. Furthermore, the use of the complete ORF of the maltose transporter gene, plus new promoter and terminator and plus new flanking sequences to provide homology to the integration site (SITl) results in a large integration cassette. In general, transformation frequencies decrease when cassettes size increases. Of course the labour involved in constructing the cassette also increases.
- This invention provides an improved method to increase the speed and extent of fermentations.
- the speed and extent of fermentations is increased by using a yeast strain transformed with a DNA molecule comprising a nucleotide sequence that encodes part of the amino acid sequence for an ⁇ -glucoside transporter. More specifically, a yeast strain is transformed with a DNA molecule comprising a nucleotide sequence that encodes part of the amino acid sequence for an ⁇ -glucoside transporter, said transformation converting the transformed host to have increased capacity for transport of maltose or maltotriose or both compared to an untransformed host.
- brewer's yeasts are believed to contain multiple genes encoding ⁇ -glucoside transporters.
- the present invention is based on the finding that in some strains of brewer's yeasts some of the genes encoding ⁇ -glucoside transporters contain defects in their coding regions (i.e., sequence errors). In this invention we show that these defects or mistakes can be repaired using DNA molecules that do not encode functional proteins and comprise DNA sequences isolated from other brewer's yeast strains or other strains of Saccharomyces cerevisae.
- the repaired genes encode functional ⁇ -glucoside transporters and the transformed strains have increased capacities for transport of maltose or maltotriose or both and ferment brewer's worts faster and more completely compared to the untransformed strains.
- genes encoding ⁇ -glucoside transporters comprise AGTl, MALxI, MPHx and MTTl (also known as MTYl). These genes are all similar to each other. Thus, different MALxI genes share 97 % identity, AGTl is 57 % identical to MAL61, MTTl is 90 % identical to MAL31 and 54 % identical to AGTl, and MPHx is 75 % identical to MAL61 and 53 % identical to AGTl. Furthermore, these genes are characteristically found in sub- telomeric regions of chromosomes. Thus, they form a closely related family. We have found that some of these genes are defective in some strains of brewer's yeasts.
- yeast strains contain AGTl genes that cannot encode full length permeases, because their coding sequences are interrupted by premature stop codons and frame shifts. If these genes produce protein products, they are truncated proteins, lacking at least one transmembrane domain and unable to transport maltose.
- the same method can also be used simultaneously to replace the promoter of the gene by a new promoter with desired characteristics.
- the expression of many genes for maltose and maltotriose transporters is strongly repressed by glucose and the expression of some of these genes requires induction by maltose or maltotriose.
- the promoters can be replaced by promoters that are not or are not strongly repressed by glucose and do not require induction by maltose or maltotriose.
- non-optimal amino acids includes both amino acids that prevent the protein from functioning as a transporter and also amino acids that limit the function of the transporter, for example by limiting its substrate specificity.
- AGTl amino acid that prevents the transporter from functioning. It is well known to those skilled in the art that the substrate specificity of catalytic proteins is determined by the nature of critical amino acids in the substrate binding sites.
- the present invention thus provides a method to increase the speed and extent of fermentations, which comprises that in the fermentation is used a yeast strain transformed with a DNA molecule comprising a nucleotide sequence that encodes part of the amino acid sequence for an ⁇ -glucoside transporter, said part not comprising a functional ⁇ - glucoside transporter, and said transformation converting the transformed host to have increased capacity for transport of maltose or maltotriose or both compared to an untransformed host.
- the present invention provides also a method for preparing from a yeast strain (the target yeast) an improved strain for fermentation, in particular for wort fermentation.
- the method comprises the steps: identifying in the target yeast a target ⁇ -glucoside transporter gene comprising a defect or defects;
- the method for preparing a yeast strain is characterized by what is stated in claim 16.
- a defect or defects in the target gene is meant a frame shift, a premature stop codon or a codon for a non-optimal amino acid.
- a defective gene having a defect or defects may not encode a functional ⁇ -glucoside transporter or a defective gene may encode an ⁇ - glucoside transporter having lower activity or narrow substrate specificity compared to an ⁇ -glucoside transporter which does not comprise the defect or defects, e.g. a naturally occurring ⁇ -glucoside transporter.
- the defect or defects may be corrected with a DNA cassette that comprises the part of the donor gene, corresponding to the defect or defects of the target gene.
- the cassette may comprise a new promoter that is not or is not strongly repressed by glucose and does not require induction by maltose or maltotriose.
- Transformants having desired integration may be screened for.
- desired integration is meant that one, two or more integrations have occurred in different chromosomes i.e. in one or more copies of the chromosomes carrying the target gene and that the transformants have increased capacity to transport maltose or maltotriose or both compared to the capacity of the target strain.
- the present invention provides also a DNA integration cassette and improved yeast strains transformed according to the methods and with the DNA integration cassette of the invention.
- the yeast strains of the invention can be used for fermentation, in particular for wort fermentation.
- the DNA integration cassette is characterized by what is stated in the claim 26, and improved yeast strains by what is stated in claims 25 and 29.
- a major advantage of the invention is that the fermentative capacity of a particular strain is increased by a minimal genetic change, which can be as little as the gain, loss or substitution of one nucleotide. This means that other properties of the strain, such as flavour production and process behaviour are not changed.
- Individual brewers can apply the invention to their own strain(s) without unwanted changes in the character of their own beers or without large changes in process conditions. However, the invention will shorten fermentation times, increase the conversion of sugars to ethanol and decrease the levels of residual sugars. Furthermore, the invention facilitates the use of higher gravity worts without leaving proportionately more residual sugars.
- a significant advantage of the invention is that the transformed strains do not contain any DNA from organisms other than Saccharomyces.
- One novel aspect of the invention is that it is directed to repairing genes or pseudogenes that are already present in the target yeast strain, and to carrying out this repair in vivo. Repair includes providing such genes with promoters that are more appropriate to a particular industrial application. Because the focus is on repair of existing genes, DNA integration cassettes of the invention are provided with flanking sequences that are very similar or identical to sequences in the gene to be repaired. This leads to another advantage of the invention, high frequencies of successful transformation with integration at the desired locus. This contrasts with the low transformation frequencies often obtained when industrial yeasts are transformed with integration cassettes having flanking sequencies that are obtained from a laboratory strain.
- Improved yeast strains are obtained in cases where the cassette has integrated into one or more copies of the defective ⁇ -glucoside transporter gene in an aneuploid or alloploid target strain.
- the defect need not be corrected in all copies of the target genes.
- By the screening methods disclosed here it is possible to find integrants, in which the defective gene has been corrected or the promoter replaced by another promoter. For example, successfull integrants grow faster on maltotriose or maltose in the presence of antimycin A than does the untransformed target strain.
- the methods of the invention it is possible to find transformants that have increased capacity to transport maltose or maltotriose or both compared to the capacity of the target strain. Also, by Southern analysis of the transformants, the size of the cleavage product indicates the success of the integration. The nature of the screened transformant can be further studied and confirmed by sequencing using appropriate PCR primers. By the methods disclosed here a person skilled in the art can produce improved yeast strains in a repeatable manner.
- Fig 1 Schematic diagram of two cassettes envisaged in the invention and the recombination events leading to their integration in the desired way.
- Target strain DNA is shown by narrow line, donor strain DNA by dotted line, other yeast DNA by thick line. Dashed lines indicate the parts of the target sequence containing one or more defects. The X symbols indicate desired cross-over events.
- Fig 2. PFGE separation of chromosomes from laboratory and brewer's strains.
- the gels were loaded with 8 x 10 cells/lane of the brewer's strains and 30 x 10 6 cells/lane of the laboratory strains.
- Strains were: lane 1, chromosome marker strain YNN295; lane 2, lager strain A15; lane 3, lager strain A24; lane 4, lager strain A64; lane 5, lager strain A72; lane 6, ale strain A60; lane 7, ale strain Al 79; lane 8, laboratory strain S288C; lane P 5 laboratory strain S150-2B; lane 10, laboratory strain CEN.PK2-1D; lane 11, laboratory strain RH144-3A; lane 12, chromosome marker strain YNN295. Chromosomes are identified on the left: chromosomes VII and XV are not resolved; chromosome II travels immediately above chromosome XIV.
- Fig 3. Detection of MAL loci.
- a PFGE gel was loaded with about 30 x 10 6 cells/lane. Strains were: lane 1, Marker YNN 295; lane 2, A15; lane 3, A24; lane 4, A64; lane 5 A72; lane 6, Al 79; lane 7, Al 80; lane 8, Al 81; lane P, A60; lane 10, S150-2B; lanell, CEN.PK2-1D and Ianel2, RH144-3A.
- Panel A shows the separated chromosomes stained with ethidium bromide. Chromosome IV and the duplex VlIfKV are indicated.
- the gel was then blotted and the blot was hybridised with the following probes: B, AGTl; C, MALI 3 (AGTl); D, MAL61; E, MAL62 and F, MAL63.
- the MAL loci are identified on the left of panel D.
- the image for panel F was darkened to make the bands more visible.
- Fig 4. Inhibition of maltose transport by trehalose. Rates of zero-trans uptake of maltose were measured at 5 mM 14 C-maltose in the presence of the indicated concentrations of trehalose. For each strain, the rate in the absence of trehalose was set at 1.00. The figure shows the reciprocal rates (1/ V) plotted against trehalose concentration for two ale yeasts, A60 (x) and A179 (•) and three lager yeasts, A15 ( ⁇ ), A24 ( ⁇ ) and A64 (A). Error bars show the range between two or three independent experiments.
- Multicopy plasmid used to express normal and potentially defective maltose transporter genes in a laboratory strain.
- This example plasmid contains the AGTl gene from the lager strain Al 5 inserted between PGKl promoter and terminator sequences.
- the plasmid also contains the URA3 gene to allow selection in an ura3-laboratory strain.
- Fig 6. Alignment of the AGTl promoter sequences of Al 5 and A24 lager strains, A60 ale strain and the Saccharomyces Genome Data Base (SGDB) sequence.
- SGDB Saccharomyces Genome Data Base
- Fig 7. The integration cassettes for Repair and New Promoter made in Example 6.
- Fig 8. Vector sequence containing the long form of the Repair and New Promoter cassette disclosed in Example 6.
- the two MspAlI restriction sites used to cut out the cassette and the ATG start codon of the AGTl gene are shown bold and underlined.
- the PGKl promoter sequence is shown in italics.
- Fig 9 Vector sequence containing the short form of the Repair and New Promoter cassette disclosed in Example 6.
- the two MspAlI restriction sites used to cut out the cassette and the ATG start codon of the A GTl gene are shown bold and underlined.
- the PGKl promoter sequence is shown in italics.
- Fig 10 Attenuation profiles during fermentations of 15 0 P wort by duplicate growths of the untransformed target strain (Al 5 A and Al 5 B), duplicate growths of Integrant 1 (Int 1 A and Int 1 B) and single growths of Integrants 2 and 14 (Int 2, Int 14).
- the apparent extract (a measure of the remaining unfermented carbohydrate) was calculated from daily measurements of the specific gravity.
- Fig 11. Attenuation profiles during fermentations of 25 0 P wort by duplicate growths of the untransformed target strain (Al 5 A and Al 5 B), duplicate growths of Integrant 1 (Int 1 A and Int 1 B) and single growths of Integrants 2 and 14 (Int 2, Int 14).
- the apparent extract (a measure of the remaining unfermented carbohydrate) was calculated from daily measurements of the specific gravity.
- Fig 12. Growth and flocculation of the target strain (Al 5) and three integrants during the wort fermentations shown in Figs 10 and 11. Solids (mainly yeast) in suspension were collected by centrifugation, washed with distilled water and dried at 105 0 C to constant mass.
- Yeast-derived volatile aroma compounds in beers produced from 25 0 P wort by the untransformed yeast (Al 5) and three integrants. Detailed Description.
- nucleotide sequence that encodes part of the amino acid sequence for an ⁇ -glucoside transporter is meant such part of a gene encoding an ⁇ -glucoside transporter that is capable of converting the transformed host to have increased capacity for transport of maltose or maltotriose or both compared to an untransformed host.
- a nucleotide sequence that encodes the part of the amino acid sequence for an ⁇ -glucoside transporter means the nucleotide sequence capable of converting a target gene comprising a defect to be functional or to function more effectively.
- nucleotide sequence that encodes the part comprises a corresponding correct sequence of the target gene, but does not comprise the complete gene, in other words "a nucleotide sequence that encodes part of the amino acid sequence” does not encode full length amino acid sequence for an ⁇ -glucoside transporter.
- nucleotide sequence that encodes part of the amino acid sequence for an ⁇ -glucoside transporter is functionally fused to a promoter with desired characteristics.
- defective ⁇ -glucoside transporter gene or an ⁇ -glucoside transporter gene having a defect or defects is meant any ⁇ -glucoside transporter gene that because of a premature stop codon or ⁇ frame shift or both does not encode a full length functional transporter or because of encoding a non-optimal amino acid at one or more positions in the amino acid sequence of the transporter produces a transporter with undesired low activity or narrow substrate specificity compared to an ⁇ -glucoside transporter that has other amino acids at the position or positions of the non-optimal amino acid or amino acids, for example a naturally occurring ⁇ -glucoside transporter.
- ⁇ -glucoside transporter is here meant transporters which carry one or more ⁇ - glucosides including maltose or maltotriose or both. Maltose and maltotriose are both ⁇ - glucosides. Some ⁇ -glucoside transporters have broad substrate specificity and can carry several ⁇ -glucosides including maltose and maltotriose. Some have narrow substrate specificity and can carry, e.g., only maltose.
- capacity to transport maltose we mean the speed at which yeast cells can take up maltose from the medium across the cell membrane and into the cell, measured, e.g., as ⁇ mol of maltose/minute/g of dry yeast.
- the expression "to have increased capacity for transport of maltose or maltotriose or both” is meant that a given mass of the transformed yeast is capable of transporting maltose or maltotriose or both into the yeast cell faster than the same mass of an untransformed host after growth under the same conditions.
- the increase is at least 10 %, preferably it is at least 30 % compared to the level transported to an untransformed host. More preferably the increase is at least 50 %.
- the maltose and maltotriose transport capacities of the transformants can be measured as described in Example 2.
- (pseudo)genes is meant here both functional and non-functional genes.
- flanking sequences mean here DNA sequences of each end of the DNA cassette, which are identical or very similar (or, as is often said, homologous) to the host DNA. They are used to direct the cassette to the desired site of the genome.
- the flanking sequences can be of any length, preferably they are at least 10 nucleotides, more preferably 10 - 1000 nucleotides, typically 40 - 400 nucleotides.
- a target brewer's yeast can be repaired by the steps:
- a defective gene for a maltose transporter is identified in the target yeast and sequenced to reveal the nature of the defect or defects. This is now called the target gene. 2.
- the corresponding functional gene is identified in another brewer's yeast strain, or baker's yeast strain or some other S . cerevisiae strain and sequeneed. This is now called the donor gene.
- a DNA cassette is made that comprises the part of the donor gene corresponding to the defective part of the target gene, this part being flanked in the cassette by DNA sequences homologous to the target gene sequences on either side of the defective part of the target gene.
- the DNA sequence used includes the ATG start codon
- a new (yeast- derived) promoter can be functionally attached before the ATG start codon.
- the 5 '-homologous flanking sequence is taken from the promoter of the target gene and is attached to the upstream end of the new promoter in the cassette.
- the target strain is then transformed with the cassette. Homologous recombination between the flanking sequences of the cassette and the corresponding sequences in the target gene results in integrative replacement of the defective part of the target gene by the corresponding functional part of the donor gene. If a new promoter was included in the cassette, this will also be integrated into the host genome and drive the corrected gene. These integration events are shown in Fig 1. Transformants are screened to identify those in which the integration has occurred as planned. Some convenient screening procedures are described below and in the Examples.
- transformants may be recovered in which one, two or more integrations have occurred in different copies of the chromosomes carrying the target gene.
- Individual transformants can be characterised by Southern and PCR analyses to show how the integration has occurred.
- the maltose and maltotriose transport capacities of the transformants can be measured to identify those with desired properties. Fermentation tests are performed on small and pilot scales to identify those transformants with improved performance. Examples 8 and 11 disclose that the desired effects on ⁇ -glucoside transport and wort fermentation are obtained when either all or less than all copies of the target gene are repaired by integration of the cassette. 7.
- the transforniants chosen by the above tests are then used in the brewery in essentially the same way as the target strain was used.
- the transformants are integrants so that no special handling is required to ensure their genetic stability.
- all their DNA is derived from brewer's or baker's yeast strains or laboratory strains of S. cerevisiae, so that no precautions appropriate to genetically modified organisms are required. Fermentations will be faster, so that yeast should be cropped and chill-back applied sooner than with the host strain. It is expected that the flavour characteristics of the produced beer will be the same as that produced by the target yeast under the same conditions.
- This present invention is now described as a number of steps, some of which are optional in certain cases.
- the information disclosed in this specification suggests that many lager strains contain defective AGTl genes similar to those of lager strains Al 5 and A24, so that the DNA cassette disclosed in Example 6 is likely to be a successful tool to carry out the invention with many lager strains.
- the invention can be practised by transforming the target lager strain with the cassette of Example 6 and selecting and screening transformants as described in Steps 7, 8 and 9.
- At least some ale strains (possibly all) and possibly some lager strains contain functional AGTl genes without the premature stop codon and frame shift found in lager strains Al 5 and A24.
- Example 5 we disclose in Example 5 that the promoters of Hie AGTl genes of ale strain A60 and lager strain Al 5 are almost identical from nucleotides -1 to -564.
- the cassette of Example 5 will work also with many ale strains and with many lager strains that do not contain in their AGTl genes the premature stop codons found in Al 5 and A24.
- transformation with the cassette of Example 6 will replace the resident promoter of these yeasts' AGTl genes by the strong constitutive PGKl promoter and at the same time can replace the amino acid sequence of the encoded transporter by that of the Agtl transporter from strain A60 over the region of amino acids 1 to at least 395.
- the Agtl transporter of A60 is an efficient carrier of maltose and maltotriose (see Examples 2 and 4) and because the Agtl proteins of A60 and other brewer's yeasts exhibit different sequences in this region (see Table 5) such transformation will often repair the target gene, by changing its amino acid sequence and improving the catalytic properties of its encoded transporter.
- the invention can be practised by transforming the target strain with the DNA cassette of Example 6 as described in Step 7 and then selecting and screening transformants as described in Steps 8 and 9. These procedures are quickly and easily performed by a person skilled in the art. If they do not yield transformants with the desired properties, then the invention is practised by first investigating the ⁇ -glucoside transporter genes of the target strain according to some or all of Steps 1 -5, and then designing and constructing a suitable DNA cassette according to Step 6 before carrying out the transformation and selection and screening of transformants.
- Step 1 Identification of (pseudo)genes for ⁇ -glucoside transporters in the target strain.
- Step 2 Kinetic characterisation of maltose and maltotriose transport by the target strain.
- Step 3 Sequencing a potentially defective ⁇ -glucoside transporter gene in the target yeast.
- Step 4 Confirmation of the non-functionality of the potentially defective gene.
- Step 5 Finding from another yeast a functional version of the target yeast's defective gene.
- Step 6 Construction of the repair cassette.
- Step 8 Analysis of the biochemical and fermentation characteristics of the transformants.
- steps 1 to 8 can be applied by a person skilled in the art to any ⁇ - glucosidase and to any Saccharomyces yeast strain.
- teaching can be applied to any brewer's yeast strain to have increased capacity for transport of maltose or maltotriose or both.
- Step 1 Identification of (pseudo)genes for ⁇ -glucoside transporters in the target strain
- the sequences of these genes are available, e.g. in the Saccharomyces Genome Data Base (SGBD). This makes it easy to design hybridisation probes that distinguish between AGTl, MPHx and MALxI genes.
- MTTl genes for maltose/maltotriose transporters and suitable probes and PCR primers for these have also been described (Diervorst et al [2005] Yeast 22, 775-788).
- the chromosomes of the target brewer's yeast are separated by pulsed field gel electrophoresis (PFGE), e.g., as described in Example 1. Blots of the gels are hybridised with specific probes to reveal which genes for ⁇ -glucoside transporters are present in the yeast.
- the method reveals both functional genes and also genes with small sequence errors that render their coding regions non-functional. For example, single nucleotide changes that introduce stop codons, frame shifts or both can render the gene non-functional. Sequence changes that alter the amino sequence of the encoded protein can also decrease or abolish its activity as an ⁇ -glucoside transporter, rendering the gene defective. These changes can be so small that they do not prevent the hybridisation of specific probes.
- Example 1 shows how this step was carried out for several industrial brewer's strains.
- the ale and lager strains analysed apparently contained several MALxI genes (expected to encode maltose transporters that cannot carry trehalose) and also AGTl genes (expected to encode maltose transporters that can carry trehalose). This agrees with Jespersen et al, (1999) Appl. Environ. Microbiol. 65:450-456.
- the lager yeasts also contained MPHx genes, expected to encode maltose transporters that cannot carry trehalose.
- the characteristics of maltose and maltotriose transport by the target strain can be determined.
- There is literature information about the substrate specificity of maltose transporters of yeast e.g., Day et al, 2002, Yeast 19:1015-27; Day et al, 2002, Appl. Environ. Microbiol. 68: 5326-5335; Chang et al, 1989, J. Bacteriol. 171:6148-6154).
- Maltose transporters encoded by AGTl can carry also trehalose, maltotriose and ⁇ -methylglucoside, those encoded by MPHx genes can carry maltose and maltotriose but not trehalose, those encoded by MAL31 and MAL61 genes can carry maltose and probably maltotriose but not trehalose.
- MPHx genes can carry maltose and maltotriose but not trehalose
- MAL31 and MAL61 genes can carry maltose and probably maltotriose but not trehalose.
- Studies of the substrate specificity of maltose transport and in particular the inhibition of maltose uptake by other ⁇ -glucosides indicate which transporters function in the target strain.
- Example 2 we show that maltose transport by several lager strains is only weakly inhibited by trehalose, maltotriose and ⁇ -methylglucoside whereas transport of maltose by ale strains was strongly inhibited by these other ⁇ -glucosides. This indicated that transporters encoded by AGTl were not important in the lager strains. It also indicates that transporters encoded by
- MALxI genes are not important in ale strains, so that it is likely some of the MALxI genes found in ale strains will prove to be defective as (see below) the AGTl genes of many lager strains are defective.
- Step 3 Sequencing of a potentially defective ⁇ -glucoside transporter gene in the target yeast
- AGTl The sequences of AGTl, MALxI, MPHx and MTTl genes are available, for example in the
- PCR primers are designed using this sequence information and the genes are amplified using appropriate forward and reverse primers.
- the amplified fragment can include the whole open reading frame (coding sequence) of the gene or also the promoter. In some cases whole genomic DNA of the target yeast is used as template.
- MALIl on chromosome VII, MAL21 on chromosome II, MAL31 on chromosome III and so on there can be several different copies on different chromosomes (MALIl on chromosome VII, MAL21 on chromosome II, MAL31 on chromosome III and so on). It is therefore an advantage to use chromosomes isolated by PFGE (as described in Example 1) as templates, because the sequence information is then immediately related to a particular MALxI gene on a particular chromosome.
- the PCR fragments are then sequenced. For example, they can be cloned using the TOPO TA cloning kit (Invitrogen) and propagated in E. coli. Plasmid DNA is isolated from independent E. coli clones and sequenced using universal Ml 3 Forward and Reverse primers to sequence the start and end of the pCO-TOPO plasmid ligated gene. Internal sequencing primers are then designed on the basis of the first sequence information.
- the same strain can contain different versions of a particular maltose transporter gene carried on different copies of the same chromosome. For example, if a yeast cell contains several different copies of chromosome VII it can also contain two or more versions of AGTl each on a different copy of chromosome VII. Mistakes can occur in PCR and sequencing reactions. Therefore several independent clones should be sequenced to identify possibly defective genes. If a sequence error is found, e.g. a premature stop codon, a frame shift or an amino acid change that is likely to be unacceptable (e.g.
- Example 3 discloses how this approach was used to show that the AGTl genes of two lager strains both contain a premature stop codon. It also discloses that in two ale yeasts the AGTl genes encoded full length genes that are likely to encode functional transporters.
- the ale genes encoded proteins with a few amino acid changes compared to the SGDB sequence for AGTl (this sequence is entered as MALxI in the SGDB because the laboratory strain used to give the SGDB sequence has the AGTl allele in its MALI locus), but none of these changes was of the non-conservative type likely to cause loss of catalytic activity.
- Step 4 Confirmation of the non-functionality of the potentially defective gene
- a potentially defective gene has been identified, it may be obvious that it cannot encode a functional transporter. For example, if it has a very premature stop codon so that the encoded protein is very much shorter than known sugar transporters, it can be assumed to be non-functional. In other cases, e.g. if it has a stop codon only slightly before the normal full length stop, it may be unclear whether or not the encoded protein can be a functional transporter.
- the functionality of the gene is tested by cloning it and expressing it (e.g., from a multicopy plasmid with a KanMx marker and G418 selection as described in Example 4) in a yeast strain that is devoid of maltose transporters. The transformed yeast is then tested to see whether or not it has acquired maltose transport activity. It is convenient, but not essential, to clone the gene under test behind a constitutive promoter, e.g. a PGKl promoter. In this way, the maltose transport activity of the transformed strain can be measured after growth on glucose.
- a constitutive promoter e.g. a PGKl promoter.
- Example 4 illustrates how cloning AGTl genes from different brewer's strains and over-expression of the cloned genes in a laboratory yeast was used to show that the potentially defective AGTl gene from a lager strain did not encode a functional maltose transporter but the apparently full length and normal A GTl genes from two ale strains did encode functional maltose transporters.
- genes that encode functional transporters with undesired low activity or narrow substrate specificity as a result of particular amino acid residues in their sequences can be identified.
- Step 5 Finding from another yeast a functional version of the target yeast's defective gene
- AGTl, MALxI, MPHx, and MTTl genes have been described in the literature and sequences that encode functional transporters are known.
- Yeast strains containing these functional genes are available and the desired genes can be amplified by PCR.
- one of these genes can be amplified by PCR from any convenient yeast strain and the amplified gene sequenced or overexpressed (e.g., from a multicopy plasmid with a KanMx marker and G418 selection as described in Example 4) in a yeast strain without maltose transport activity to confirm that it encodes a functional transporter.
- Examples 3 and 4 disclose how the AGTl genes from two ale strains were amplified by PCR, sequenced and over-expressed in a laboratory strain lacking maltose transport activity. Both these AGTl genes encoded full length, 616 amino acid proteins, with no obvious defects. Over-expression of each gene in the laboratory strain caused a large increase in maltose transport activity. The new maltose transport activity was strongly inhibited by maltotriose, which indicates that the transporter encoded by each of the ale-derived AGTl genes is also able to transport maltotriose. The ability to carry maltotriose effectively is a desirable property for a maltose transporter in brewer's yeast.
- maltotriose transport activity can also be determined by measuring the change in extracellular pH caused by the uptake of protons that accompanies uptake of maltotriose catalysed by the transporters, which are H + - symports.
- Step 6 Construct a repair cassette
- strains of brewer's yeasts contain genes for ⁇ -glucoside transporters with defects in their sequences, but that nevertheless comprise DNA sequences of hundreds of nucleotides that are extremely similar to or even identical to homologous stretches in functional genes.
- This situation is surprising, because current strains of brewer's yeasts have evolved for hundreds of years in brewer's wort where maltose and maltotriose are the main sugars. It is widely believed that their multiple genes for ⁇ - glucoside transporters have evolved in response to this environment. It is therefore surprising that mutations that apparently destroy the functionality of the encoded transporters have survived and even spread through the yeast population, so that two apparently unrelated lager strains (A 15 and A24) contain the same defect.
- the defect(s) in the maltose transporter gene of the target yeast may consist of only one nucleotide or may extend over a few hundred nucleotides.
- a simple repair cassette is a DNA molecule cloned from the donor gene (by PCR or restriction enzymes or any other method) and comprising the correct version of the defective sequence flanked on each side by enough homologous sequence to facilitate recombination. This cassette and the desired integration event are shown schematically in the upper part of Fig 1. The cassette comprises between about 20 and a few hundred nucleotides of homologous sequence.
- the present invention is concerned with the repair of defective genes and (see "2. Cassette for Repair and New Promoter) optionally replacement of promoters by more advantageous promoters.
- the method of the present invention does not result in elimination of any functional gene in the genome of the target host.
- Maltose transporters from yeast comprise eight transmembrane domains. Absence of one or more of these domains is likely to destroy the function of the transporter.
- the encoded protein is unlikely to be a functional transporter.
- the cassette can be joined in frame to a promoter and over-expressed in a yeast strain lacking maltose transport and the transport activity of the transformant measured (methods are outlined in Step 5).
- the cassette is so short compared to the foil length gene that it is clear it does not encode a functional transporter.
- the cassette comprises a DNA sequence cloned from the donor gene (by PCR or restriction enzymes or any other method) and comprising the correct version of the defective sequence from the ATG start to at least 10 nucleotides, preferably 50 to 1000 nucleotides and more preferably 50 to 400 after the position of the last defective nucleotide of the target gene (or pseudogene).
- the 3 '-end of this sequence provides for homologous recombination with the target gene, the desired cross-over occuring 3 '- to the last defect in the target gene.
- the cassette contains a suitable yeast promoter.
- this promoter sequence is a stretch of flanking sequence that is homologous to the promoter region of the target gene.
- This stretch of flanking sequence is preferably between 50 and 1000 nucleotides, more preferably 50 and 400 nucleotides . It is obtained by cloning the promoter region of the target gene.
- the promoter regions of some maltose transporter genes differ significantly from the promoter sequences provided in, e.g., the SGDB.
- the AGTl promoters of some lager and ale strains are almost identical to each other from nucleotides -1 to -564, but differ markedly from the SGDB sequence.
- the Cassette for Repair and New Promoter can integrate into the target gene as shown in the lower part of Fig 1.
- the result is to correct the defective part of the target gene and simultaneously put the ORF (open reading frame, the part of a gene that encodes a protein) under the control of the new promoter.
- the new promoter is chosen to give the desired expression characteristics.
- the promoter chosen was the PGKl promoter from a laboratory strain of S. cerevisiae. This promoter is relatively strong, does not require maltose for induction and is not repressed by glucose.
- Example 8 The result (Example 8) is that although the target strain, A 15, contains little or no maltose and maltotriose transport activity after growth on glucose, the transformed strain contains a powerful maltose/maltotriose transport activity. Because of this powerful maltose/maltotriose transport activity, the transformed strain ferments brewer's wort faster and more completely than the untransformed target strain (Example 9).
- the target strain can be transformed with the integration cassette and successful transformants selected by any suitable method known in the art. A convenient method is described in Example 7.
- the target strain (A 15) was co-transformed with an integration cassette of the Repair and New Promoter type and a self replicating plasmid containing the KanMx marker, giving improved resistance to the antibiotic G418.
- the particular integration cassettes used (Example 6) comprised the PGKl promoter functionally linked to the first 1482 bp of the AGTl ORF from ale strain, A60. At the 5'- end of the PGKl promoter was flanking sequence homologous to the promoter of the defective AGTl gene of strain Al 5.
- this flanking sequence was nucleotides -1 to -387 and in another nucleotides -1 to -703. After transformation the cells were allowed to recover by growth on YP/glucose overnight. They were then plated onto YP/maltotriose containing antimycin A and G418. The first colonies to appear (in about 3- 4 days) were selected. These are expected to contain the KanMx-plasmid (because they can grow in the presence of G418). It is also expected that the cassette has integrated as desired, giving a functional AGTl gene driven by a PGKl promoter so that an efficient maltotriose transporter is produced in the glucose-grown cells before they are plated onto maltotriose.
- transformants are grown on YP/glucose, YP/maltose or other media, harvested and their maltose and maltotriose transport capacities measured. This is illustrated in Example 8.
- transformants are grown, e.g., in brewer's wort, to get enough cell mass to carry out wort fermentations. No selection pressure is needed, because the transformants are integrants. Brewer's wort is then pitched with the transformed yeast and with the untransformed target yeast. Transformants cause faster fermentations and also leave less residual maltose and maltotriose (especially important when high gravity worts are used). The production of aroma compounds and the organoleptic qualities of the produced beer are measured using standard methods. Most transformants produce beer with the same character as that made by the target strain. These fermentation analyses are illustrated in Example 9.
- the above Detailed Description explains how the invention is used to repair maltose transporter genes in brewer's strains and replace their promoters by new promoters.
- the transformed brewer's strains ferment worts faster and more completely than the untransformed strains.
- Slow and incomplete fermentation of worts is a major problem as brewers try to use stronger worts in production.
- so-called very high gravity (VHG) worts with original extracts above 16 0 P frequently cause problems with very slow fermentations and large amounts of residual maltotriose and maltose.
- VHG very high gravity
- EP 0 306 107 Bl describes baker's yeast strains (not brewer's yeast) in which the complete coding sequence of a maltose transporter gene has been provided with a new promoter and terminator (e.g. from the yeast ADHl gene) and this construct is then integrated into a yeast gene.
- This strategy results in the loss of one gene from the yeast.
- EP 0 306 107 recognised this problem, and therefore chose to integrate the DNA construct into the SITl gene (EP 0 306 107 , loc .cit see p 14, lines 17 et seq.), in the belief that the SITl gene is not needed by the baker's yeast during the industrial process.
- the transformed yeast lacks at least one copy of the SITl gene This could have unforeseen consequences, especially in the beer production process, where the exact physiological behaviour of the yeast impacts on flavour formation and yeast handling.
- the use of the complete ORF of the maltose transporter gene, plus new promoter and terminator and plus new flanking sequences to provide homology to the integration site (SITl) results in a large integration cassette.
- the integration cassettes of our invention are relatively small molecules: the cassettes disclosed in Example 6 are only 3.7 and 3.4 kbp and integrated with high frequencies. In general, transformation frequencies decrease when cassettes size increases. Of course the labour involved in constructing the cassette also increases.
- Kodama et al [1995] J. Am. Soc. Brew Chem. 53, 24-29) have described a brewer's yeast containing high-copy-number plasmids comprising a maltose transporter gene (MAL6T) under the control of a constitutive promoter.
- MAL6T maltose transporter gene
- This transformed strain fermented VHG (24 0 P) wort faster than the uncontrolled strain.
- This transformed strain contains non-yeast (bacterial) DNA, which is a disadvantage for applications in the food and drink industry because of public attitudes and official regulations.
- the high-copy-number plasmids are not genetically stable and selection pressure is required to maintain these plasmids in the yeast.
- Kodama et al carried out their fermentations in wort containing the antibiotic G418 to provide selection pressure. This is unacceptable on the industrial scale and with a product for human consumption.
- This example illustrates how to identify in a target strain the genes for maltose/maltotriose transporters, including pseudogenes that hybridise with gene-specific reporters but contain small sequence errors that render them non-functional.
- PFGE Pulsed Field Gel Electrophoresis
- Yeast strains were propagated in YP/2% glucose for 2 days at 30 0 C and then harvested by centrifugation (3000 x g, 5 min, 4°C). Supernatants were decanted and cells resuspended in 10 ml of 4 0 C 50 mM EDTA, pH 8. Cell concentrations were determined by OD 6 oo measurements and 8 to 60 x 10 6 cells were placed in each sample plug. Sample plugs were prepared using the CHEF Genomic DNA Plug Kit for Yeast (Bio Rad). Cells were centrifuged (3 min, 5000 * g, 4°C) and resuspended in the kit's Cell Suspension Buffer.
- Lyticase was added to 150 U/ml final concentration followed immediately by melted 2% Clean Cut agarose to a final concentration of 0.75%. These mixtures were dispensed into molds and allowed to solidify to produce plugs that could be loaded into the sample wells of the PFGE apparatus. After the agarose solidified the sample plugs were pushed out of the molds into the kit's Lyticase buffer containing 170 U lyticase/ml. Plugs were incubated in the lyticase solution for 2 h at 37°C. Lyticase buffer was removed and the plugs rinsed with sterile water.
- Plugs were incubated in the kit's Proteinase K reaction buffer containing 240 U of proteinase K/ml for 18 h at 50 0 C. After that the plugs were washed four times in the kit's washing buffer (1 h per wash) with gentle agitation and stored at 4°C in the same buffer. Sample plugs were loaded into the wells of a 1.0% Ultra Pure agarose (Bio Rad) gel. PFGE was performed at 14°C in 0.5 x TBE buffer (89 mM Tris, 89 mM boric acid, 2 mM EDTA, pH 8).
- a CHEF Mapper XA Pulsed Field Electrophoresis System (Bio Rad) was used with the following settings: 6V/cm in 120° angle; pulse length increasing linearly from 26 to 228 s; total running time, 22 h 52 min.
- a commercial chromosome marker preparation from S. cerevisiae strain YNN295 (Bio Rad) was used for molecular mass calibration. Following electrophoresis, the gels were stained with ethidium bromide and scanned and quantified with a Typhoon imager (Amersham Biosciences, Espoo, Finland) to estimate the total amount of DNA in each lane.
- Chromosome blotting and hybridization Chromosomes separated by PFGE were partially depurinized by soaking the gels in 0.25 M HCl for 20 min. After that the gels were treated with 0.5 M NaOH/1.5 M NaCl for 30 min at room temperature and neutralized in 1.5 M NaCl/0.5 M Tris buffer, pH 7.5, for 30 min. The DNA was then transferred to a nylon filter (Hybond-N, Amersham Biosciences) by capillary blotting in 20 ⁇ SSC (3 M NaCl/0.3 M sodium citrate, pH 7.0). After blotting, DNA was UV cross- linked to the membrane.
- Prehybridization was performed at 48°C for 2 h in a hybridization mixture containing 5* SSPE (3 M NaCl/0.2 M sodium phosphate/0.1 M EDTA, pH 7.4), 5 x Denhardt's solution, 50% formamide, 100 ⁇ g single strand salmon sperm DNA and 1 ⁇ g poly-A-DNA/ml.
- the hybridization mixture was then replaced with a fresh lot containing a labeled DNA probe at 0.5 x 10 6 cpm/ml.
- the probes were labeled with 32 P by the random primer protocol using Hexalabel Plus DNA Labeling Kit (Fermentas Life Sciences, Hanover, MD). Unless stated otherwise, hybridization was carried out at 42 °C overnight.
- filters were washed twice with 2 ⁇ SSC at room temperature for 5 min and then in 0.1 x SSC/0.1 % sodium dodecyl sulfate (SDS) at 65°C for 40 min. Filters were exposed over night to a phosphoimager screen, which was then scanned and signals quantified with Image Quant software (Amersham Biosciences).
- PFGE resolved 15 chromosome bands from the marker yeast strain, YNN295 (Fig 2). Chromosomes VII and XV were presumed to comigrate as a duplex. Chromosome FV, faint in Fig. 2, is clearly visible in the brewer's yeasts at higher DNA loads (Fig. 3A).
- the four laboratory strains all differed from each other and from the marker strain in the size of one or more chromosomes. For the brewer's strains, greater differences appeared, including bands not present in the marker strain.
- chromosomes VII; III; II; XI and VIII Bands at or near the positions of chromosomes that often carry MAL loci, i.e., chromosomes VII; III; II; XI and VIII, could be tentatively identified, although chromosome III was smaller in the lager strains than in the YNN295 marker strain. Chromosome III could not be identified in the ale strains based on mobility alone. Blots of these PFGE gels were hybridized sequentially with specific probes for the transporter, maltase and activator genes at MAL loci (Table 1).
- AGTl and MAL61 primers were the same as in (Jespersen et al, 1999, Appl. Environ. Microb. 65, 450-456).
- d Primers were designed with the Saccharomyces Genome Database primer design programme (http://seq.yeastgenome.org/cgi-bin/web-primer).
- e MPHx primers were the same as in (Day et al, 2002 Yeast, 19, 1015-1027).
- MALxI genes are 97% identical and the MAL61 probe is expected to hybridize to all of them.
- the transporter gene is the AGTl allele instead of MALIl (Han et al, 1995, MoI. Microbiol. 17:1093-1107) and we used a specific AGTl probe to detect this allele.
- MALx2 genes are 97% identical and the MAL62 probe is expected to hybridize to all of them.
- MALI 3 MAL23 and MAL43 are 91-94% identical to MAL63, but MAL33 and an allele of MALI 3, found in MALI loci containing AGTl and referred to in this study as MALI 3(AGTl), share only about 75% identity to each other and to other MALx3 sequences.
- the MAL61, MAL62 and MAL63 probes also bound to the VII/XV duplex of all six brewer's strains (Figs 3D, E and F). This pattern suggests that the brewer's strains each contained at least two kinds of chromosome VII, one with a MALI locus containing the AGTl and MALI 3(AGTl) alleles and another with a MALI locus containing MALIl and MALI 3 alleles. In contrast, MAL61 and MAL63 did not bind at this duplex in the laboratory strains (MAL62 did; Fig 3E), suggesting that the single copy of chromosome VII in the (haploid) laboratory strains contained only the AGTl and AGTl (MALI 3) alleles.
- Three lager strains (A24, A64 and A72), one ale strain (A60) and one laboratory strain (CEN.PK2-1D) contained complete MAL2 loci on chromosome III. Chromosome III is possibly missing from the other ale strain (see Al 79 in Fig 2).
- MALI with AGTl and MAL31 (AGTl) alleles
- MAL3 loci are insufficient for a maltose positive phenotype.
- the maltose-positive laboratory strain, CEN.PK2-1D had a genotype similar to the maltose negative strains plus a complete MAL2 locus.
- MAL13(A) indicates the MALI 3(AGTl) allele.
- MAL2, MAL3 and MAL4 loci either were completely absent or contained all three genes MALxI, MALx2 and MALx3, shown as, e.g., MAL21-23.
- d Parentheses indicate that the hybridization detected was very weak.
- the MAL62 probe (but not other probes) bound weakly near chromosome EK in all strains, stronger in brewer's strains.
- f In A60 MAL61, MAL62 and MAL63 probes bound weakly to a chromosome ⁇ 1.3 Mbp in size.
- This example illustrates how to characterise kinetically the maltose and maltotriose uptake properties of the target yeast. Such characterisation can indicate which genes detected by hybridisation may be defective.
- D-[U- 14 C]-maltose was from Amersham Biosciences (Espoo, Finland). Maltose for uptake experiments (minimum purity 99%), maltotriose (minimum purity 95%) and trehalose were from Sigma-Aldrich (Helsinki, Finland). Maltose for growth media and ⁇ - methylglucoside (methyl- ⁇ -glucopyranoside) were from Fluka (Helsinki, Finland).
- strains Four industrial lager strains (Al 5, A24, A64 and A72) and two industrial ale strains (A60 and A 179) from VTTs collection were used as typical representatives of strains in current industrial use. Strains Al 80 and Al 81 were isolated as single cell clones from A179 and appeared identical to A179. The laboratory strains were S288C, S150-2B, CEN.PK2-1D (VW-IB), RH144-3A and the chromosome marker strain, YNN295, from Bio-Rad (Espoo, Finland).
- strains were grown in media with 1% yeast extract/2% Difco (Sparks, MD) Bacto-peptone (YP) containing 2% maltose for 2 days at 25 0 C. All strains reached an ODeoo of 10 - 12, except for the three laboratory strains S288C, S150-2B and RH144-3A, whose OD 600 remained below 1.4. These three laboratory strains were defined as Mal-negative.
- Yeasts were grown in 100 ml of YP/4% maltose in 250 ml flasks shaken at 150 rpm and 25°C to an OD 60 O of 6 to 12, corresponding to about 2 - 4 mg dry yeast/ml. Under these conditions residual maltose was between 2 and 0.5%.
- the yeast were harvested by centrifugation (10 min, 9000 x g, O 0 C), washed with ice-cold water, then with ice cold 0.1 M tartrate/Tris pH 4.2, and finally suspended in the same buffer to 200 mg fresh yeast/ml. Zero-trans 14 C-maltose uptake rates were immediately determined essentially as described by Lucero et al.
- Trehalose is the preferred substrate of the Agtl transporter but is not a substrate for the MaIx 1 and MPHx transporters. Therefore, trehalose is expected to inhibit competitively maltose transport by the Agtl transporters, but not necessarily to affect transport by the Malxl and Mphl transporters. Maltose transport in both ale strains was strongly inhibited (50% at 10 mM trehalose and over 80% at 100 mM trehalose).
- maltose- grown Al 5 does not express maltose transporters capable of carrying trehalose, whereas in A24 and A64 these transporters can account for 30-50% of the maltose transport capacity at 5 mM maltose.
- maltotriose and ⁇ -methylglucoside strongly inhibited maltose transport by both ale strains, but only weakly inhibited transport by the lager strains (Table 3).
- Maltotriose is a substrate of Agtl, Mphx and Mal31 transporters
- ⁇ -methylglucoside is a substrate of Agtl and MPHx, but not of the Mal31 transporter.
- AGTl gene sequences of each strain were amplified by PCR with the specific primers AGTl frw 5 '-ATGAAAAATATCATTTCATTGGT-S ' (SEQ ID NO: 15) and AGTl rev 5 '- TTAACATTTATCAGCTGCATTT-S' (SEQ ID NO.-16) from both ends of the gene.
- Genomic DNA of four brewer's strains (A 15, A24, A60 and A 179) was used as the template.
- the PCR-generated fragments were cloned using the TOPO TA cloning kit (Invitrogen, Carlsbad, CA) and propagated in E. coli. Plasmid DNA was isolated from independent E. coli clones and sequenced.
- AGTl genes were amplified from four brewer's yeasts in three (Al 5), 2 (A24), 3 (A60) and 2 (Al 79) independent PCR reactions, ligated into the pCR-TOPO plasmid and independent clones isolated and sequenced (Tables 4 and 5). Of the eight whole gene sequences from the two ale strains (A60 and Al 79), seven encoded full length, 616 amino acid proteins, similar to the sequence in the Saccharomyces Genome Database (SGD; http://www.yeastgenome.org). AGTl is entered as MALIl because it is the allele of MALIl present in the S288C strain of the SGD.
- SGD Saccharomyces Genome Database
- AGTl (pseudo)genes were cloned from the lager strain Al 5 and from two ale strains, A60 and A 179.
- the genes were ligated between the PGKl promoter and terminator sequences of a multicopy plasmid, to give, e.g., YEplacl95PGKPT-AGTl(A15) shown in Fig. 5.
- This plasmid has an URA3 gene to allow for selection in ura3 -laboratory strains.
- Strains CEN-PK2- 1 D and S 150-2B were transformed with these plasmids and transformants selected on media lacking uracil.
- the transformants were grown up in glucose (this represses the endogenous maltose transport activity of CEN-PK-ID; S150-2B is a maltose- negative yeast, unable to grow with maltose as sole carbon source and lacking significant maltose transport activity), harvested and their maltose transport activity determined as described in Example 2 under standard conditions (5 mM 14 C-maltose, pH 4.2, 20 0 C) in the presence and absence of 50 mM maltotriose. Results are shown in Table 6. Table 6. Maltose transport activity of laboratory strains carrying ,4 GTl (pseudo)genes from different brewer's yeasts. The yeast were grown on YP/2 % glucose. ND, not determined.
- maltose transport activity of the untransformed host or host carrying the empty plasmid was low and 50 mM maltotriose caused only moderate (8 - 18 %) inhibition.
- Transformation with the plasmid carrying the AGTl gene from the ale strain A60 caused a large increase in maltose transport activity, confirming that this ale gene encodes a functional transporter. This activity was strongly inhibited by maltotriose, which is expected if maltotriose is also a substrate of the encoded transporter.
- transformation with plasmid comprising the AGTl pseudogene (with premature stop codon) from the lager strain Al 5 did not increase the maltose transport activity.
- This example shows how functionality of transporter genes can be examined by over- expressing the genes in laboratory yeast strains and measuring the maltose transport activity of the transformants.
- Example 5 Determination of the promoter sequences of AGTl genes by chromosome walking
- This example illustrates how the promoter sequences of defective and functional genes can be determined.
- the determined sequences can be used to give homologous flanking sequences upstream of the new promoter used to practise the invention with the Repair and New Promoter cassette and the Cassette for New Promoter Alone described in Step 6 of the Detailed Description.
- Chromosome walking was applied to DNA from the two lager strains, Al 5 and A24, and the ale strain A60. The method used was that described by Mueller, P.R. and Wold, B. 1989. Science 246: 780-786.
- Fig 6 the sequences obtained are compared to the AGTl (MALIl) promoter sequence given in the SGDB. From nucleotides -1 to -316 the promoter sequences of Al 5 lager and A60 ale strains were both almost identical to the SGDB sequence (two changes at -8 and - 152 were shared by the two brewer's yeasts). From nucleotides -221 to -316 also the A24 lager sequence was identical to the other three (the A24 sequence from-1 to -221 is not yet available). From nucleotides -317 to -806, the three brewer's sequences were essentially identical to each other, apart from a deletion in the ale strain between -572 and -593.
- AGTl MALIl
- Integration cassettes were constructed in pBluescript II SK(-) vector (Stratagene, La Jolla, CA).
- a 1485 bp long PGKl promoter fragment and a 370 bp long PGKl terminator fragment were cloned from a laboratory strain of S. cerevisiae and ligated onto a YEplacl95 multicopy vector as a Hindlll fragment.
- the promoter-terminator complex was now detached with Hindi ⁇ l from the YEplacl95 vector and ligated into the pBluescript vector at its Hindlll site.
- the gene encoding Agtl was amplified by PCR using brewer's yeast ale strain A60 as template.
- the following PCR primers for the sense and antisense directions were used 5'-CGAGATCTCGATGAAAAATATCATTTCATTGGT-S' (SEQ ID NO: 18) and 5'-GCAGATCTGCTTAACATTTATCAGCTGCATTT ⁇ ' (SEQ ID NO: 19), respectively.
- BgHl restriction sites to facilitate the next cloning step were introduced by PCR and are underlined in the primer sequences.
- the PCR product was cloned into a pCR-TOPO vector and the sequence of the AGTl gene was verified by using eight sequencing primers; universal Ml 3 Forward and Reverse primers to sequence the start and end of the pCR- TOPO plasmid ligated AGTl gene and 6 internal primers from the coding strand.
- the AGTl gene was excised from the pCR-TOPO plasmid with BgRl enzyme and ligated between the PGKl promoter and terminator at the BgRl site in the pBluescript plasmid described above.
- AGTl promoter fragments of two different lengths were amplified by PCR. Brewer's yeast lager strain Al 5 was used as template. Two different primer pairs were used: AGTl prom Cl -705 FRW and AGTl prom Cl -1 REV to amplify an AGTl promoter fragment from - 705 to -1 and the primer pair AGTlprom Cl -387 FRW and AGTl prom Cl -1 REV to amplify an AGTl promoter fragment from -387 to -1 of the AGTl promoter. EcoRI and Mspall restriction sites were introduced by PCR on the 5' ends of these fragments and an EcoRI site to their 3' ends to facilitate the next cloning steps and the final detachment of the integration cassette. Primers:
- AGTlprom Cl -1 REV 5'-CGGAATTCCGATTATAATATTTTTTTAGTTGT-S' (SEQ ID NO:22)
- the AGTl promoter fragments were ligated to a pCR-TOPO plasmid and their sequences were verified.
- the promoter fragments were excised from the pCR-TOPO vector with EcoRI and ligated into the pBluescript vector already possessing the PGKl promoter- AGT1(A6O)-PGK1 terminator complex. Ligation was carried out to the EcoRI site, which is located next to the 5' end of the PGKl promoter.
- two different kinds of integration cassettes pBluescript-Short-Integration and pBluescript-Long Integration
- the cassettes were excised from the pBluescript vector by using MspAlI. It detaches the 3.38 kbp (possessing 387 bp long AGTl promoter flank) and 3.70 kbp (possessing 705 bp long AGTl promoter flank) integration cassettes. Detachment takes place at the 5' end of the ligated AGTl promoter fragments at the newly introduced MspAlI site and on the other side of the cassette at the MspAlI site located in the AGTl gene at position 1482.
- This example illustrates how to construct Repair and New Promoter Cassettes.
- the particular cassettes described in this example are suitable for repairing the defective AGTl genes in lager strains like Al 5 and A24 and can be used as such to practise the invention.
- the one with the shorter (387 bp) AGTl -derived flanking sequence can also be used to replace the resident promoter of the AGTl genes of at least all strains in which the sequence of the resident promoter from -1 to -387 is similar to that found in the lager strain Al 5 and ale strain A60 (which are virtually identical from -1 to -564).
- the longer one can also be used for this purpose in cases where the promoter sequences are similar between - 703 and about -650 to -600.
- Al 5 brewer's yeast strain was transformed with the Repair and New Promoter cassettes (pBluescript-Short-Integration and pBluescript-Long Integration) constructed in Example 6. These cassettes contain part of the ale strain AGTl sequence and are expected to create constitutive expression of AGTl. Transformation was performed as co-transformation with pKX34 selection plasmid containing KanMx marker and giving resistance to the antibiotic G418.
- the pellet was resuspended in freshly made IxTE, 0.1 M LiAc to a concentration of 2 x 10 9 cells/ml and incubated for 15 min at 30 0 C without agitation. Cells were then divided into 50 ⁇ l aliquots (1 x 10 cells/aliquot).
- Cells of each aliquot were resuspended into 1 ml YPD and incubated for 17 h at 3O 0 C with shaking (250 rpm). Next cells were centrifuged for 15 sec and supernatants decanted. Cells of each aliquot were resuspended into 1 ml sterile water and 100 ⁇ l aliquots were plated on selective plates YPD/G418 (200 ⁇ g/ml) or YP/2%maltotriose/Antimycin A (3 ⁇ g/ml)/G418(200 ⁇ g/ml). Plates were incubated at 30 0 C up to six days.
- Transformation frequencies were counted from colonies appearing on YPD/G418 (200 ⁇ g/ml) plates. On YPD/G418 (200 ⁇ g/ml) plates colonies appeared after two days at 30 0 C (Table 7). Transformation frequencies were around 50-110 transformants/ ⁇ g total transforming DNA (cassette + selection plasmid DNA). Table 7. Colonies appearing on YPD/G418 (200 ⁇ g/ml) plates after 2 days incubation at 3O 0 C.
- Short cassettes 2 and 5 are two similar cassettes digested from two independent clones of pBluescript-Short- Integration cassette construct (clones 2 and 5).
- Long cassettes 11 and 12 are two similar cassettes digested from two independent clones of pBluescript-Longlntegration cassette constructs (clones 11 and 12).
- Table 8 Colonies appearing on YP/2%maltotriose/Antimycin A (3 ⁇ g/ml )/G418 (200 ⁇ g/ml) Half (500 ⁇ l) of each transformation was plated to these plates. The table shows the number of new colonies appearing on Days 2-6 (no colonies were visible before Day 2).
- Table 8 transformants were also tested by a PCR strategy using primers recognising the PGKl promoter and a sequence in the AGTl ORF distal to the part of this ORF that is in the integration cassette. From the host no PCR product is expected, whereas integration according to the plan (Fig 1 lower part) should yield a 2257 bp product. This product was seen in all 55 tested transformants.
- Table 8 transformants were also tested by another PCR strategy using primers recognising the A GTl promoter and a sequence early in the AGTl ORF were used.
- a product of 684 bp is expected from the host and a larger product (2184 bp) from integrants where the PGKl promoter has been inserted between the AGTl promoter and the AGTl ORF. All 36 tested transformants showed the 2184 bp product.
- Integrants expressing constitutive maltose transport activity are first grown on media in the absence on G418. Single cell colonies recovered from these growths are tested for ability to grow in the presence of G418. Those that cannot grow have lost the pKX34 plasmid conferring resistance to G418, and are selected. These cured integrants contain no DNA from any non-Saccharomyces organism. The cured integrants are then grown in brewer's wort and pitched into brewer's wort in 2 L tall tubes. For example the methodology described by Rautio & Londesborough ([2003] J. Inst. Brew, 109, 251-261) can be used. The integrants cause faster fermentations and residual sugars are lower especially when the original gravity of the wort is very high (20 - 25 0 P). The yeast-derived aroma compounds of the green beers are measured by gas chromatographic analyses.
- the desired integration event is as shown in the lower panel of Fig 1.
- this scheme there is one cross-over event between the AGTl promoter sequences in the resident gene and in the cassette and another cross-over event between AGTl coding sequences 3 '- to the position of the sequence mistake(s).
- This is expected to happen, because these cross-over events involve the two ends of the cassette.
- all the coding sequence in the cassette is extremely similar to the corresponding part of the coding sequence (open reading frame or ORF) in the resident gene, cross-over events could also occur 5'- to the position of the sequence mistakes.
- Such cross-over events would cause integration events that either do not repair the sequence mistakes in the target gene or do not introduced the new promoter, or both.
- the table shows the origin of the nucleotides at positions 827, 997, 1123, 1183 (the site of the premature STOP codon) , 1465 and 1647 of the AGTl ORF for 20 independent clones from 7 integrants. Uncertain and unread sequence positions are indicated by a query (?). These results show that cassettes made as described in Example 6 integrate in the desired way with high efficiency so that about 90 % of the integrants selected by the strategy described in Example 7 contain chimaeric A GTl genes where the sequence mistake of the gene in the target strain has been repaired according to the plan shown in the lower panel of Fig 1.
- Integrant 1 A 7 A60 A60 A60 A60 A60 A15 A15
- Integrant 2 A 1 A60 A60 A60 A60 A60 A15 Integrant 2 A 2 A60 ? A60 A60 A60 A15 Integrant 2 A 3 A60 A60 A60 A60 A60 A15
- Example 7 Three of the integrants isolated in Example 7 (Integrants 1, 2 and 14) were cured of the pKX34 plasmid by growth in the absence of G418 (see Example 9). These cured integrants and the untransformed target yeast (Al 5) were grown in 15 0 P brewer's wort at 18 0 C to give enough yeast mass for pitching of 16 0 P (high gravity) and 25 0 P (very high gravity, VHG) worts for 2-litre scale fermentations in stainless steel tall tubes. The worts used, fermentation conditions and analysis methods are typical for laboratory scale brewer's wort fermentation.
- Attenuation profiles for 15 and 25 0 P worts are shown in Figs 10 and 11, respectively. All three integrants attenuated both worts faster and jnore completely than the untransformed yeast.
- the lowest apparent extract reached by Al 5 (2.50 ⁇ 0.02 0 P) was reached at least 2 days (42 h) earlier by all three integrants, and the apparent extracts reached by the integrants in 7 days (163 h) were 0.14 to 0.19 0 P lower than reached by A15 in the same time.
- Table 11 shows that residual maltose and, especially, maltotriose were lower in the final beers made by the integrants than in those made by the untransformed target strain, Al 5.
- the integrants have the desired property of being better able than the untransformed target strain to consume these sugars under the harsh conditions at the end VHG wort fermentations.
- Glucose was completely consumed by all the yeast strains much earlier in the fermentations.
- the increased sugar consumption resulted in markedly higher final concentrations of ethanol from integrants than from the untransformed yeast.
- Viabilities of yeast cropped at the end of the fermentations were at least as high for integrants as for the untransformed yeast.
- Fig 13 compares the yeast-derived, volatile aroma compounds produced during the fermentations of the 25 0 P wort. There were no significant differences between Integrants 1 and 2 and the untransformed yeast, showing that the transformation of this invention does not interfere with flavour properties of the yeast strain. Integrant 14 also produced a similar aroma profile as the untransformed parent, with the exception that in the green beer analysed there was still more acetaldehyde; however, this is likely to be reduced during the lagering of the green beer.
- Integrants 1 and 14 were made with the long form of the cassette described in Example 6 and Integrant 2 with the short form. In Integrant 14, the cassette had integrated into all copies of the resident AGTl gene, whereas in Integrants 1 and 2 both repaired and original versions of the A GTl gene were present (see Table 9). Thus, both kinds of cassette perform as desired and it is not critical whether all or only some copies of the resident gene are repaired: in both cases fermentation ability is improved.
- This example shows that the present invention provides genetically modified brewer's yeasts with improved fermentation speed and extent by repairing defective genes for ⁇ - glucoside transporters in industrial brewer's yeasts.
- the genetic modification did not introduce any DNA from non-Saccharomyces organisms: the new DNA sequences are from ale and laboratory strains of S. cerevisiae.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20050870 | 2005-09-01 | ||
FI20050870A FI20050870L (fi) | 2005-09-01 | 2005-09-01 | Parannettu fermentointimenetelmä hiivageenejä korjaamalla |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007026049A2 true WO2007026049A2 (en) | 2007-03-08 |
WO2007026049A3 WO2007026049A3 (en) | 2007-05-10 |
Family
ID=35151329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FI2006/000292 WO2007026049A2 (en) | 2005-09-01 | 2006-08-31 | Improved method for fermentation by repairing yeast genes |
Country Status (2)
Country | Link |
---|---|
FI (1) | FI20050870L (fi) |
WO (1) | WO2007026049A2 (fi) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2189525A1 (en) * | 2008-09-09 | 2010-05-26 | Suntory Holdings Limited | Hybrid alpha-glucoside transporter |
CN101952425B (zh) * | 2008-09-09 | 2012-08-15 | 三得利控股株式会社 | 葡萄糖诱导性失活及降解抗性转运蛋白基因及其用途 |
EP3663392A1 (en) * | 2013-08-07 | 2020-06-10 | Amyris, Inc. | Methods for stabilizing production of acetyl-coenzyme a derived compounds |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1217074A1 (en) * | 2000-12-22 | 2002-06-26 | Universiteit Leiden | Nucleic acid integration in eukaryotes |
-
2005
- 2005-09-01 FI FI20050870A patent/FI20050870L/fi not_active Application Discontinuation
-
2006
- 2006-08-31 WO PCT/FI2006/000292 patent/WO2007026049A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1217074A1 (en) * | 2000-12-22 | 2002-06-26 | Universiteit Leiden | Nucleic acid integration in eukaryotes |
Non-Patent Citations (4)
Title |
---|
KOMADA Y ET AL: "Improvement of Maltose Fermentation Efficiency: Constitutive Expression of MAL Genes in Brewing Yeasts" JOURNAL OF THE AMERICAN SOCIETY OF BREWING CHEMISTS, AMERICAN SOCIETY OF BREWING CHEMISTS, ST.PAUL, MN,, US, vol. 53, no. 1, 1995, pages 24-29, XP002996798 ISSN: 0361-0470 cited in the application * |
RAUTIO JARI ET AL: "Maltose transport by brewer's yeasts in brewer's wort." JOURNAL OF THE INSTITUTE OF BREWING, vol. 109, no. 3, 2003, pages 251-261, XP001249133 ISSN: 0046-9750 cited in the application * |
STEARMAN R ET AL: "YIpDCE1 - an integrating plasmid for dual constitutive expression in yeast" GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER, AMSTERDAM, NL, vol. 212, no. 2, 8 June 1998 (1998-06-08), pages 197-202, XP004122921 ISSN: 0378-1119 & DATABASE EMBL 23 June 1998 (1998-06-23), STEARMAN R.: "Integrating expression vector YIpDCE1, complete sequence" Database accession no. EM_SY:AF039102 * |
VIDGREN VIRVE ET AL: "Characterization and functional analysis of the MAL and MPH loci for maltose utilization in some ale and lager yeast strains" APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 71, no. 12, December 2005 (2005-12), pages 7846-7857, XP002419699 ISSN: 0099-2240 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2189525A1 (en) * | 2008-09-09 | 2010-05-26 | Suntory Holdings Limited | Hybrid alpha-glucoside transporter |
EP2189525A4 (en) * | 2008-09-09 | 2012-03-28 | Suntory Holdings Ltd | HYBRID ALPHA-GLUCOSIDIC TRANSPORTER |
CN101952425B (zh) * | 2008-09-09 | 2012-08-15 | 三得利控股株式会社 | 葡萄糖诱导性失活及降解抗性转运蛋白基因及其用途 |
US8735092B2 (en) | 2008-09-09 | 2014-05-27 | Suntory Holdings Limited | Glucose-induced inactivation/degradation-resistant transporter gene and use thereof |
EP3663392A1 (en) * | 2013-08-07 | 2020-06-10 | Amyris, Inc. | Methods for stabilizing production of acetyl-coenzyme a derived compounds |
US11230716B2 (en) | 2013-08-07 | 2022-01-25 | Amyris, Inc. | Methods for stabilizing production of acetyl-coenzyme A derived compounds |
Also Published As
Publication number | Publication date |
---|---|
FI20050870A0 (fi) | 2005-09-01 |
FI20050870L (fi) | 2007-03-02 |
WO2007026049A3 (en) | 2007-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nagasawa et al. | Cloning and nucleotide sequence of the alcohol acetyltransferase II gene (ATF2) from Saccharomyces cerevisiae Kyokai No. 7 | |
Vidgren et al. | Characterization and functional analysis of the MAL and MPH loci for maltose utilization in some ale and lager yeast strains | |
Vidgren et al. | Improved fermentation performance of a lager yeast after repair of its AGT1 maltose and maltotriose transporter genes | |
Verstrepen et al. | Late fermentation expression of FLO1 in Saccharomyces cerevisiae | |
JPS61282097A (ja) | 発酵製品の分離法 | |
CA2621202A1 (en) | Method for analyzing genes of industrial yeasts | |
AU2015371749A1 (en) | Yeast for preparing alcoholic beverages | |
Kodama et al. | Isolation and characterization of a gene specific to lager brewing yeast that encodes a branched-chain amino acid permease | |
Vidgren et al. | Characterization of the Saccharomyces bayanus‐type AGT1 transporter of lager yeast | |
EP4172301B1 (en) | Low diacetyl yeast | |
Petersen et al. | Structural heterozygosis at genes IL V2 and IL V5 in Saccharomyces carlsbergensiss | |
ZA200604835B (en) | Yeast strains with improved fructose fermentaion capacity | |
US20220127552A1 (en) | Maltotriose metabolizing mutants of saccharomyces eubayanus | |
WO2007026049A2 (en) | Improved method for fermentation by repairing yeast genes | |
US20110294119A1 (en) | Novel methods of differentiating yeast strains and/or determining genetic stability of yeast strains, and uses thereof | |
JPH07509372A (ja) | 酵母凝集性遺伝子及びそれを含有する酵母 | |
Tamai et al. | HO gene polymorphism in Saccharomyces industrial yeasts and application of novel HO genes to convert homothallism to heterothallism in combination with the mating-type detection cassette | |
WO1999051746A1 (en) | Improved yeast strain | |
CA3240648A1 (en) | Methods of preventing inhibition of flavour production in yeast | |
WO2024192063A1 (en) | Recombinant yeast having haze positive phenotype | |
JP2016077160A (ja) | 高速発酵酵母細胞 | |
ALE | TIONS 748 MALTOSE AND MALTO | |
JP2008263848A (ja) | ビール酵母の凝集に対する培養液の影響を評価する方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06794070 Country of ref document: EP Kind code of ref document: A2 |